@article{f4d6ab17d0244eeba5825fa659cf5492,
title = "Direct interaction of PP2A phosphatase with GABAB receptors alters functional signaling",
abstract = "Addictive drugs usurp the brain{\textquoteright}s intrinsic mechanism for reward, leading to compulsive and destructive behaviors. In the ventral tegmental area (VTA), the center of the brain{\textquoteright}s reward circuit, GABAergic neurons control the excitability of dopamine (DA) projection neurons and are the site of initial psychostimulant-dependent changes in signaling. Previous work established that cocaine/methamphetamine exposure increases protein phosphatase 2A (PP2A) activity, which dephosphorylates the GABABR2 subunit, promotes internalization of the GABAB receptor (GABABR) and leads to smaller GABABR-activated G-protein-gated inwardly rectifying potassium (GIRK) currents in VTA GABA neurons. How the actions of PP2A become selective for a particular signaling pathway is poorly understood. Here, we demonstrate that PP2A can associate directly with a short peptide sequence in the C terminal domain of the GABABR1 subunit, and that GABABRs and PP2A are in close proximity in rodent neurons (mouse/rat; mixed sexes). We show that this PP2AGABABR interaction can be regulated by intracellular Ca2 +. Finally, a peptide that potentially reduces recruitment of PP2A to GABABRs and thereby limits receptor dephosphorylation increases the magnitude of baclofen-induced GIRK currents. Thus, limiting PP2Adependent dephosphorylation of GABABRs may be a useful strategy to increase receptor signaling for treating diseases.",
keywords = "GABA(B), GIRK, Inhibition, PLA, Phosphatase, Trafficking",
author = "Xiaofan Li and Miho Terunuma and Deeb, {Tarek G.} and Shari Wiseman and Pangalos, {Menelas N.} and Nairn, {Angus C.} and Moss, {Stephen J.} and Slesinger, {Paul A.}",
note = "Funding Information: This work was supported in part by the National Institutes of Health (National Institute on Drug Abuse Grant DA037170 to P.A.S. and S.J.M.; National Institute on Alcohol Abuse and Alcoholism Grant AA018734) to P.A.S.; NationalInstituteofNeurologicalDisordersandStrokeGrantsNS051195,NS056359,NS081735,R21NS080064,and NS087662 to S.J.M.; and National Institute of Mental Health Grant MH097446 to S.J.M.); a 2017 NARSAD Young InvestigatorGrant(X.L.);andtheYale/NIDANeuroproteomicsCenter(GrantP30DA018343toS.J.M.andA.C.N.).We thank the Slesinger and Moss laboratories for discussions on the experiments. Funding Information: This work was supported in part by the National Institutes of Health (National Institute on Drug Abuse Grant DA037170 to P.A.S. and S.J.M.; National Institute on Alcohol Abuse and Alcoholism Grant AA018734) to P.A.S.; National Institute of Neurological Disorders and Stroke Grants NS051195, NS056359, NS081735, R21NS080064, and NS087662 to S.J.M.; and National Institute of Mental Health Grant MH097446 to S.J.M.); a 2017 NARSAD Young Investigator Grant (X.L.); and the Yale/NIDA Neuroproteomics Center (Grant P30 DA018343 to S.J.M. and A.C.N.). We thank the Slesinger and Moss laboratories for discussions on the experiments. Publisher Copyright: Copyright {\textcopyright} 2020 the authors",
year = "2020",
month = apr,
day = "1",
doi = "10.1523/JNEUROSCI.2654-19.2020",
language = "English",
volume = "40",
pages = "2808--2816",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "14",
}